The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.00
Bid: 255.00
Ask: 256.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.392%)
Open: 254.00
High: 259.50
Low: 254.00
Prev. Close: 254.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to ASIC consultation paper

22 Aug 2019 11:52

RNS Number : 9455J
CMC Markets Plc
22 August 2019
 

22 August 2019

CMC Markets Plc

Response to ASIC consultation paper and update on current trading

 

CMC Markets plc ("CMC") notes the announcement by the Australian Securities and Investments Commission ("ASIC") issued today regarding a consultation on the application of product intervention powers on the issuance and distribution of binary options and contracts for difference to retail clients.

In its consultation paper, ASIC are seeking industry comment on the proposed introduction of regulatory changes, covering binary options, leverage ratio limits, margin close-out, negative balance protection, inducements and disclosure. The changes proposed are similar to that already implemented in other jurisdictions, including ESMA. ASIC is required to consult with the industry before making a product intervention order. Any product intervention order which ASIC makes is only effective for up to an initial period of 18 months.

Fair outcomes for clients have always been a focus for CMC. Benefitting from its proprietary technology and focus on targeting higher valued experienced clients, CMC is well prepared to respond quickly and manage any regulatory changes as required.

CMC noted in its Q1 Trading Update on 25 July 2019 that the imposition of limits by ESMA had resulted in a period of transition, where clients adjusted their trading behaviour to the new environment and CMC adjusted its model accordingly. Following the stabilisation noted in the Q1 update, the Board is pleased to see that net operating income has performed strongly through the summer.

Australia is an important part of CMC's balanced and diverse portfolio of regions and products, with a large non-leveraged stockbroking business and a leveraged CFD business aimed at more sophisticated investors. In the last financial year ended 31 March 2019, the Australian business as a whole represented 31% of the Group's net operating income. Within that, CFD net revenue constituted 20% of Group CFD (and Spread bet) net revenue and 17% of the Group's net operating income.

CMC values regular and transparent dialogue with regulators. Key to this dialogue is CMC's belief in a consistent approach to regulation, a level playing field, and raising standards in the industry. CMC will continue to engage with ASIC over the coming months and will harness the experience gained from recent UK and European regulatory changes when responding and adapting to any measures implemented by ASIC.

Outlook

On the basis of recent and current trading as noted above, the Board believes that CMC is currently on track to report net operating income and Profit Before Tax for the year ended 31 March 2020 that is marginally ahead of the upper end of the current range of analysts' forecasts.1,2

Forward looking statements

 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward looking statements to reflect events or developments occurring after the date such statements are published.

 

Enquiries

 

CMC Markets Plc +44 (0) 20 7170 8200

Euan Marshall, Interim Chief Financial Officer

 

Camarco +44 (0) 20 3757 4980

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

Notes to Editors

 

1. The range of publicly available analysts' forecasts for net operating income for 2020 is £149.2m to £159.6m, with a mean of £154.0m based on company compiled consensus as at the date of this announcement.

2. The range of publicly available analysts' forecasts for Profit Before Tax for 2020 is £23.4m to £26.3m, with a mean of £24.6m based on company compiled consensus as at the date of this announcement.

 

About CMC Markets plc

CMC Markets plc, whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 13 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPUUSRRKBAWUAR
Date   Source Headline
28th Sep 20177:00 amRNSH1 2018 Pre-Close Trading Update
15th Sep 20172:41 pmRNSDirector/PDMR Shareholding
14th Sep 201710:02 amRNSBoard Change
7th Sep 20179:21 amRNSDirector/PDMR Shareholding
5th Sep 20174:25 pmRNSDirector/PDMR Shareholding
9th Aug 201711:24 amRNSDirector/PDMR Shareholding
1st Aug 201712:06 pmRNSDirector/PDMR Shareholding
27th Jul 20173:53 pmRNSResult of AGM
27th Jul 20177:00 amRNSBoard Change
27th Jul 20177:00 amRNSQ1 Interim Management Statement
14th Jul 201710:00 amRNSBoard Changes
7th Jul 201711:38 amRNSDirector/PDMR Shareholding
26th Jun 20175:32 pmRNSNotice of AGM
26th Jun 20179:30 amRNSHolding(s) in Company
23rd Jun 201710:12 amRNSHolding(s) in Company
21st Jun 20179:45 amRNSHolding(s) in Company
15th Jun 20179:01 amRNSHolding(s) in Company
13th Jun 201710:18 amRNSHolding(s) in Company
8th Jun 20177:00 amRNSFinal Results
7th Jun 20173:46 pmRNSDirector/PDMR Shareholding
5th Jun 201710:37 amRNSHolding(s) in Company
26th May 20179:00 amRNSReorganisation of Management Structure
23rd May 20178:00 amRNSBoard Change
9th May 201712:30 pmRNSDirector/PDMR Shareholding
9th May 20179:26 amRNSHolding(s) in Company
9th May 20177:00 amRNSCMC Markets welcomes BaFin consultation conclusion
10th Apr 20173:37 pmRNSDirector/PDMR Shareholding
6th Apr 20173:43 pmRNSHolding(s) in Company
30th Mar 20177:00 amRNSPre-Close Trading Update
8th Mar 201712:55 pmRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSMajor Partnership with ANZ
21st Feb 20174:02 pmRNSDirector/PDMR Shareholding
13th Feb 20171:30 pmRNSIssue of Equity
9th Feb 201711:59 amRNSDirector/PDMR Shareholding
9th Feb 201711:57 amRNSIssue of Equity
8th Feb 201710:14 amRNSDirector/PDMR Shareholding
26th Jan 20177:00 amRNSQ3 Interim Management Statement
23rd Jan 20179:13 amRNSHolding(s) in Company
18th Jan 20173:20 pmRNSHolding(s) in Company
10th Jan 201712:01 pmRNSDirector/PDMR Shareholding
3rd Jan 201710:33 amRNSDirector/PDMR Shareholding
19th Dec 20169:26 amRNSHolding(s) in Company
9th Dec 201610:08 amRNSHolding(s) in Company
9th Dec 20167:00 amRNSResponse to BaFin Consultation Paper
7th Dec 201612:14 pmRNSDirector/PDMR Shareholding
6th Dec 201611:27 amRNSCMC Markets response to FCA Consultation Paper
5th Dec 20167:55 amRNSHolding(s) in Company
1st Dec 20165:43 pmRNSHolding(s) in Company
1st Dec 20165:32 pmRNSHolding(s) in Company
30th Nov 20161:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.